Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04070703 · ClinicalTrials.gov registry record · NA
Tai Ji Quan and Cognitive Function in Older Adults With Mild Cognitive Impairment
A NA study of Mild Cognitive Impairment, sponsored by Oregon Research Institute.
- Active
- Registry status
- NA
- Development phase
- 318
- Enrollment target
- 1
- Study location
NCT04070703: Active NA study of Mild Cognitive Impairment, sponsored by Oregon Research Institute.
NCT04070703 is a NA study of Mild Cognitive Impairment that is active but no longer recruiting, run by Oregon Research Institute. The registered enrollment target is 318 participants, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04070703, a NA study of Mild Cognitive Impairment, is active but no longer recruiting, sponsored by Oregon Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 318 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the efficacy of a cognitively enhanced exercise intervention - Tai Ji Quan: Moving to Maintain Brain Health in improving global cognitive function and dual-task ability in older adults with mild cognitive impairment.
Primary Outcome
The Montreal Cognitive Assessment scale measures change in global cognitive function from baseline to 6 months. The scale scores range from 0 to 30 points, with higher scores indicating better cognitive functioning.
Conditions Studied
Interventions
- BEHAVIORAL The Go for Exercise & Healthy Aging Project
Study Locations (1)
Oregon
- Oregon Research Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 318 participants |
| Start Date | 2019-10-15 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What the registry record for NCT04070703 still lists
NCT04070703 is an interventional study that assigns participants to a tested intervention. The registered 318 participants enrollment target is mid-sized for trials with a published cap, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which The Go for Exercise & Healthy Aging Project is the first listed.
NCT04070703 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04070703 about?
NCT04070703 is a clinical study titled "Tai Ji Quan and Cognitive Function in Older Adults With Mild Cognitive Impairment". To determine the efficacy of a cognitively enhanced exercise intervention - Tai Ji Quan: Moving to Maintain Brain Health in improving global cognitive function and dual-task ability in older adults with mild cognitive impairment.
What is the current status of trial NCT04070703?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 318 participants. The study started on 2019-10-15. Estimated completion is 2025-12-30.
What conditions does trial NCT04070703 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment.
What interventions are being tested in trial NCT04070703?
The interventions under investigation include: The Go for Exercise & Healthy Aging Project (BEHAVIORAL).
Who is sponsoring clinical trial NCT04070703?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04070703 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04070703's enrollment target sits among peer trials
318 32nd of 205 higher than 174 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Impact of Intensive Computerized Cognitive Training
RECRUITING · NA
-
Multimodal Investigation of Neural Plasticity
RECRUITING · NA
-
GAMES Intervention in MCI (Mild Cognitive Impairment)
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05488340 · 318 participants · Phase 2
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
- NCT05675735 · 318 participants · NA
Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder
- NCT05895786 · 318 participants · Phase 3
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NCT06051617 · 318 participants · Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI